ABSTRACT
The present guidelines are aimed at residents and board-certified physicians in the fields of dermatology, pediatrics, pediatric dermatology and pediatric rheumatology as well as policymakers and insurance funds. They were developed by dermatologists and pediatric dermatologists in collaboration with pediatric rheumatologists using a formal consensus process (S2k). The guidelines highlight topics such as disease severity, quality of life, treatment goals as well as problems associated with off-label drug therapy in children. Trigger factors and diagnostic aspects are discussed. The primary focus is on the various topical, systemic and UV-based treatment options available and includes recommendations for use and treatment algorithms. Other aspects addressed herein include vaccinations in children and adolescents with psoriasis as well as various disease subtypes such as guttate psoriasis, diaper psoriasis, pustular psoriasis and psoriatic arthritis. Finally, we also provide recommendations for imaging studies and the diagnostic workup to rule out tuberculosis prior to initiating systemic treatment. Note: This article constitutes part 1 of the Sk2 guidelines for the treatment of psoriasis in children and adolescents. Part 2 will be published in the next issue. It contains chapters on UV therapy, systemic treatment, tonsillectomy and antibiotics, vaccinations, guttate psoriasis, psoriatic arthritis, complementary medicine, as well as imaging studies and diagnostic workup to rule out tuberculosis prior to systemic treatment.
Subject(s)
Practice Guidelines as Topic/standards , Psoriasis/drug therapy , Psoriasis/pathology , Administration, Topical , Adolescent , Arthritis, Psoriatic/diagnosis , Child , Child, Preschool , Comorbidity , Consensus , Dermatology , Humans , Infant , Infant, Newborn , Off-Label Use/statistics & numerical data , Psoriasis/psychology , Psoriasis/radiotherapy , Quality of Life/psychology , Rheumatology , Severity of Illness Index , Ultraviolet RaysABSTRACT
Three widely used anthropomorphic phantoms are analysed with regard to their suitability for the efficiency calibration of whole-body counters (WBCs): a Bottle Manikin Absorber (BOMAB) phantom consisting of water-filled plastic containers, a St Petersburg block phantom (Research Institute of Sea Transport Hygiene, St Petersburg) made of polyethylene bricks and a mathematical Medical Internal Radiation Dose (MIRD) phantom, each of them representing a person weighing 70 kg. The analysis was performed by means of Monte Carlo simulations with the Monte Carlo N-Particle transport code using detailed mathematical models of the phantoms and the WBC at Forschungszentrum Jülich (FZJ). The simulated peak efficiencies for the BOMAB phantom and the MIRD phantom agree very well, but the results for the St Petersburg phantom are considerably higher. Therefore, WBCs similar to that at FZJ will probably underestimate the activity of incorporated radionuclides if they are calibrated by means of a St Petersburg phantom. Finally, the results from this work are compared with the conclusions from other studies dealing with block and BOMAB phantoms.
